Orbimed Advisors as of Sept. 30, 2017
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 138 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alexion Pharmaceuticals | 4.9 | $511M | 3.6M | 140.29 | |
Biogen Idec (BIIB) | 4.9 | $510M | 1.6M | 313.12 | |
Celgene Corporation | 4.7 | $489M | 3.4M | 145.82 | |
Boston Scientific Corporation (BSX) | 3.7 | $391M | 13M | 29.17 | |
Merck & Co (MRK) | 3.4 | $351M | 5.5M | 64.03 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $315M | 2.1M | 152.04 | |
Puma Biotechnology (PBYI) | 2.8 | $291M | 2.4M | 119.75 | |
Eli Lilly & Co. (LLY) | 2.5 | $263M | 3.1M | 85.54 | |
Regeneron Pharmaceuticals (REGN) | 2.5 | $256M | 573k | 447.12 | |
CIGNA Corporation | 2.3 | $237M | 1.3M | 186.94 | |
Amgen (AMGN) | 2.2 | $234M | 1.3M | 186.45 | |
Agilent Technologies Inc C ommon (A) | 2.2 | $234M | 3.6M | 64.20 | |
Wright Medical Group Nv | 2.2 | $231M | 8.9M | 25.87 | |
Aetna | 2.1 | $222M | 1.4M | 159.01 | |
Clovis Oncology | 1.9 | $197M | 2.4M | 82.40 | |
Incyte Corporation (INCY) | 1.9 | $196M | 1.7M | 116.74 | |
Anthem (ELV) | 1.7 | $176M | 928k | 189.88 | |
Clementia | 1.7 | $176M | 10M | 16.89 | |
Array BioPharma | 1.7 | $174M | 14M | 12.30 | |
Abbvie (ABBV) | 1.7 | $175M | 2.0M | 88.86 | |
Loxo Oncology | 1.5 | $159M | 1.7M | 92.12 | |
Gilead Sciences (GILD) | 1.5 | $156M | 1.9M | 81.02 | |
Edwards Lifesciences (EW) | 1.4 | $152M | 1.4M | 109.31 | |
Johnson & Johnson (JNJ) | 1.4 | $146M | 1.1M | 130.01 | |
Immunomedics | 1.3 | $140M | 10M | 13.98 | |
Beigene (BGNE) | 1.3 | $136M | 1.3M | 103.46 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $128M | 1.1M | 117.49 | |
Ascendis Pharma A S (ASND) | 1.2 | $122M | 3.4M | 36.25 | |
Audentes Therapeutics | 1.1 | $116M | 4.1M | 28.01 | |
Mylan Nv | 1.1 | $113M | 3.6M | 31.37 | |
Jazz Pharmaceuticals (JAZZ) | 1.1 | $110M | 749k | 146.25 | |
Select Medical Holdings Corporation (SEM) | 1.0 | $107M | 5.6M | 19.20 | |
Thermo Fisher Scientific (TMO) | 1.0 | $101M | 534k | 189.20 | |
Juno Therapeutics | 0.9 | $92M | 2.0M | 44.86 | |
Ironwood Pharmaceuticals (IRWD) | 0.9 | $91M | 5.8M | 15.77 | |
Pfizer (PFE) | 0.8 | $88M | 2.5M | 35.70 | |
Corvus Pharmaceuticals (CRVS) | 0.8 | $86M | 5.4M | 15.94 | |
Illumina (ILMN) | 0.8 | $79M | 399k | 199.20 | |
Shire | 0.7 | $77M | 500k | 153.14 | |
Magellan Health Services | 0.7 | $76M | 883k | 86.30 | |
Allergan | 0.7 | $77M | 374k | 204.95 | |
Universal Health Services (UHS) | 0.7 | $74M | 669k | 110.94 | |
UnitedHealth (UNH) | 0.7 | $74M | 380k | 195.85 | |
Global Blood Therapeutics In | 0.7 | $74M | 2.4M | 31.05 | |
Aerie Pharmaceuticals | 0.7 | $70M | 1.4M | 48.60 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $69M | 744k | 93.07 | |
Medtronic (MDT) | 0.7 | $68M | 879k | 77.77 | |
Bluebird Bio (BLUE) | 0.6 | $66M | 482k | 137.35 | |
Intellia Therapeutics (NTLA) | 0.6 | $66M | 2.7M | 24.85 | |
Bristol Myers Squibb (BMY) | 0.6 | $65M | 1.0M | 63.74 | |
Allergan Plc pfd conv ser a | 0.6 | $65M | 88k | 737.82 | |
Stryker Corporation (SYK) | 0.6 | $60M | 421k | 142.02 | |
Intuitive Surgical (ISRG) | 0.6 | $59M | 56k | 1045.89 | |
Achillion Pharmaceuticals | 0.6 | $59M | 13M | 4.49 | |
Insmed (INSM) | 0.6 | $59M | 1.9M | 31.21 | |
Gw Pharmaceuticals Plc ads | 0.5 | $57M | 561k | 101.49 | |
Integra LifeSciences Holdings (IART) | 0.5 | $55M | 1.1M | 50.48 | |
Mallinckrodt Pub | 0.5 | $55M | 1.5M | 37.37 | |
Insys Therapeutics | 0.5 | $55M | 6.2M | 8.88 | |
Viewray (VRAYQ) | 0.5 | $55M | 9.5M | 5.76 | |
Kala Pharmaceuticals | 0.5 | $54M | 2.4M | 22.84 | |
Galapagos Nv- (GLPG) | 0.5 | $53M | 524k | 101.75 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $50M | 6.4M | 7.75 | |
Nevro (NVRO) | 0.4 | $45M | 495k | 90.88 | |
eHealth (EHTH) | 0.4 | $44M | 1.8M | 23.89 | |
Radius Health | 0.4 | $43M | 1.1M | 38.55 | |
ImmunoGen | 0.4 | $42M | 5.5M | 7.65 | |
Pieris Pharmaceuticals | 0.4 | $42M | 7.3M | 5.76 | |
Synergy Pharmaceuticals | 0.4 | $40M | 14M | 2.90 | |
Momenta Pharmaceuticals | 0.4 | $39M | 2.1M | 18.50 | |
Dermira | 0.4 | $38M | 1.4M | 27.00 | |
Spark Therapeutics | 0.4 | $38M | 430k | 89.16 | |
Alpine Immune Sciences | 0.4 | $38M | 3.3M | 11.60 | |
Selecta Biosciences | 0.3 | $34M | 1.8M | 18.25 | |
Dimension Therapeutics | 0.3 | $32M | 5.4M | 6.00 | |
Nabriva Therapeutics | 0.3 | $32M | 3.9M | 8.19 | |
Glaukos (GKOS) | 0.3 | $28M | 837k | 33.00 | |
Assembly Biosciences | 0.2 | $26M | 748k | 34.92 | |
Synlogic | 0.2 | $25M | 1.3M | 19.02 | |
Intercept Pharmaceuticals In | 0.2 | $22M | 386k | 58.04 | |
Dbv Technologies S A | 0.2 | $22M | 513k | 42.44 | |
Obseva Sa | 0.2 | $21M | 2.6M | 8.14 | |
Natera (NTRA) | 0.2 | $20M | 1.6M | 12.89 | |
Envision Healthcare | 0.2 | $20M | 441k | 44.95 | |
Sinovac Biotech (SVA) | 0.2 | $19M | 2.7M | 7.05 | |
Vanda Pharmaceuticals (VNDA) | 0.2 | $17M | 968k | 17.90 | |
Neurocrine Biosciences (NBIX) | 0.2 | $18M | 285k | 61.28 | |
Zai Lab (ZLAB) | 0.2 | $18M | 658k | 27.00 | |
Xencor (XNCR) | 0.2 | $17M | 747k | 22.92 | |
Novo Nordisk A/S (NVO) | 0.1 | $16M | 330k | 48.15 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $16M | 1.9M | 8.19 | |
Cti Biopharma | 0.1 | $16M | 5.0M | 3.19 | |
Hca Holdings (HCA) | 0.1 | $15M | 187k | 79.59 | |
Coherus Biosciences (CHRS) | 0.1 | $14M | 1.1M | 13.35 | |
Invitae (NVTAQ) | 0.1 | $14M | 1.5M | 9.37 | |
Steadymed | 0.1 | $14M | 4.2M | 3.35 | |
Wright Medical Group Rtsn V | 0.1 | $14M | 8.7M | 1.55 | |
Novus Therapeutics | 0.1 | $13M | 2.5M | 5.21 | |
NuVasive | 0.1 | $12M | 221k | 55.46 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $12M | 15M | 0.81 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $11M | 1.8M | 6.27 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $11M | 2.3M | 4.85 | |
Argenx Se (ARGX) | 0.1 | $11M | 500k | 22.61 | |
Heron Therapeutics (HRTX) | 0.1 | $11M | 650k | 16.15 | |
Verona Pharma Plc ads (VRNA) | 0.1 | $10M | 667k | 15.35 | |
Newlink Genetics Corporation | 0.1 | $9.0M | 881k | 10.18 | |
D Fluidigm Corp Del (LAB) | 0.1 | $8.8M | 1.7M | 5.04 | |
Teva Pharmaceutical Industries (TEVA) | 0.1 | $7.1M | 406k | 17.60 | |
Alkermes (ALKS) | 0.1 | $7.4M | 145k | 50.84 | |
Sarepta Therapeutics (SRPT) | 0.1 | $6.8M | 150k | 45.36 | |
Fluidigm Corporation convertible cor | 0.1 | $7.4M | 10M | 0.74 | |
Aeglea Biotherapeutics | 0.1 | $7.2M | 1.5M | 4.93 | |
Deciphera Pharmaceuticals | 0.1 | $7.5M | 394k | 18.99 | |
Halozyme Therapeutics (HALO) | 0.1 | $6.1M | 350k | 17.37 | |
Redhill Biopharma Ltd cmn | 0.1 | $6.1M | 565k | 10.81 | |
Crispr Therapeutics (CRSP) | 0.1 | $6.7M | 372k | 17.87 | |
Zimmer Holdings (ZBH) | 0.1 | $5.7M | 49k | 117.08 | |
Glycomimetics (GLYC) | 0.1 | $4.7M | 338k | 13.99 | |
Seres Therapeutics (MCRB) | 0.1 | $4.7M | 295k | 16.04 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $5.1M | 437k | 11.70 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $5.5M | 7.0M | 0.79 | |
Sierra Oncology | 0.1 | $5.7M | 3.7M | 1.55 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $2.9M | 2.2M | 1.33 | |
Valeant Pharmaceuticals Int | 0.0 | $2.8M | 195k | 14.33 | |
Marinus Pharmaceuticals | 0.0 | $3.3M | 568k | 5.87 | |
Otonomy | 0.0 | $2.1M | 644k | 3.25 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $1.9M | 635k | 2.95 | |
Orexigen Therapeutics Inc note 2.750%12/0 | 0.0 | $2.0M | 5.2M | 0.39 | |
Biolinerx Ltd-spons | 0.0 | $1.2M | 1.0M | 1.12 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $560k | 500k | 1.12 | |
Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $600k | 500k | 1.20 | |
Affimed Therapeutics B V | 0.0 | $735k | 327k | 2.25 | |
Noveliontherapeuti.. | 0.0 | $703k | 100k | 7.03 | |
Alimera Sciences | 0.0 | $338k | 250k | 1.35 | |
Versartis | 0.0 | $123k | 50k | 2.46 | |
Xtant Med Holdings | 0.0 | $342k | 475k | 0.72 | |
Roka Bioscience | 0.0 | $147k | 202k | 0.73 | |
Medigus Ltd sponsord | 0.0 | $134k | 60k | 2.23 |